down arrow

Concord Biotech

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE338H01029
INR
1,660.00
59.35 (3.71%)

Apr 11, 12:53 PM

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryConcord Biotech VS Pharmaceuticals & Drugs
 
1D
3.71%
2.07%
1W
1.19%
0.02%
1M
1.74%
1.72%
YTD
-24.89%
-3.53%
1Y
10.21%
0.45%
3Y
%
27.83%
5Y
%
141.91%
10Y
%
161.01%
  • Stock Absolute Returns
  • Sensex Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.55%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-12.45%
0%
-12.45%
1 Year
10.21%
0.53%
10.74%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Latest dividend: 8.75 per share ex-dividend date: Jun-21-2024

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Industry stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Market Cap stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
stock-summaryRisk Adjusted Returns v/s Sensex
Risk Adjusted Returns v/s Sensex stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available